Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study

Afatinib, Exon, Erlotinib, Medicine, Lung cancer, Internal medicine, Erlotinib Hydrochloride, Oncology, Gefitinib, Epidermal growth factor receptor, Mutation, Cancer, Biology, Genetics, Gene